AstraZeneca secures ex-China license for Sino Biopharmaceutical's experimental COPD drug

By Andrew Silver July 8 (Reuters) - AstraZeneca will pay a subsidiary of Sino Biopharmaceutical $200 million upfront for the ...

AstraZeneca to pay $200M upfront for Sino Biopharmaceutical’s COPD drug license deal

Sino Biopharmaceutical inks a licensing deal with AstraZeneca for a respiratory drug, with milestones and royalties worth ...

AstraZeneca in China experimental COPD drug deal; upfront payment $200 million

By Andrew Silver July 8 (Reuters) - AstraZeneca will license a subsidiary of Sino Biopharmaceutical's experimental chronic ...
Fierce Biotech

AstraZeneca pens $2.1B Sino deal for challenger to Merck’s COPD drug Ohtuvayre

AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & ...
pharmaphorum

AZ pays $200m upfront for Sino Bio COPD drug

In another big-ticket licensing deal with a Chinese biotech, AstraZeneca has claimed rights to a drug candidate for chronic ...
AOL

Can drugs like Ozempic help with COPD?

GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate that as of 2019, about 400 million people around ...
Medscape

Costs of Drugs Can Be Breathtaking for COPD Patients

For patients with chronic obstructive pulmonary disease (COPD), the Global Initiative on Obstructive Lung Disease recommends long-term term pharmacologic and nonpharmacologic therapies based on each ...
News Medical

Study explains why COPD patients develop tolerance to roflumilast drug

Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly ...
Rolling Out

Diabetes drugs show promise in reducing COPD complications

Recent medical research reveals promising developments in the treatment of patients suffering from both diabetes and chronic obstructive pulmonary disease. The study, involving nearly 394,000 adults, ...
RAPS

FDA Revises Draft Guidance on COPD Drug Development

The US Food and Drug Administration (FDA) on Thursday released a revised version of its draft guidance intended to help pharmaceutical companies develop products to treat the lung disease known as ...
AOL

FDA approves new COPD drug developed by firm in Raleigh. First new treatment in a decade

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...
Medical Xpress

Cost and confusion drive COPD medication misuse, studies suggest

Medication nonadherence among people with chronic obstructive pulmonary disease (COPD) is a result of affordability and lack of knowledge about medications, among other factors, and leads to increased ...